Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β 2 -Glycoprotein I
Authors:
- 15 September 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (11) , 1108-1115
Abstract
Background —Immunization with β 2 -glycoprotein I (β2GPI), the probable target of autoimmune anticardiolipin antibodies, results in experimental antiphospholipid syndrome in different mouse strains. The present study was undertaken to evaluate the effect of β2GPI immunization on the progression of atherosclerosis. Methods and Results —In the first experiment, 3 groups of LDL receptor–deficient (LDL-RD) mice (n=15 per group) were immunized with either β2GPI or ovalbumin or were not immunized and were fed a chow diet for 12 weeks. In a second experiment, 3 groups of LDL-RD mice (n=10 per group) were immunized similarly and fed an atherogenic diet for 6 weeks. All β2GPI-immunized mice developed high titers of anti-β2GPI antibodies as well as a specific lymph node proliferation to β2GPI. The average cholesterol levels did not differ between the mice fed similar diets, regardless of the immunization protocol. Atherosclerosis was enhanced in the β2GPI-immunized mice (mean aortic lesion, 26 000±5700 μm 2 ) in comparison with their ovalbumin-immunized (mean, 3000±1099 μm 2 ; P 2 ; P 2 ) was larger than the ovalbumin-immunized mice (mean, 81 250±12 933 μm 2 ; P =NS) or the nonimmunized controls (mean, 75 625±7281 μm 2 ; P =NS). The atherosclerotic plaques in the β2GPI-immunized mice appeared to be more mature, and denser infiltration of CD4 lymphocytes was present in the subendothelium of the aortic sinuses from this group of mice. Conclusions —The results of the present study provide the first direct evidence for the proatherogenic effect of β2GPI immunization and establish a new model for immune-mediated atherosclerosis.Keywords
This publication has 38 references indexed in Scilit:
- Induction of Experimental Antiphospholipid Antibody Syndrome in PL/J Mice Following Immunization With β2GPIAmerican Journal of Reproductive Immunology, 1997
- Infectious agents and atherosclerotic vascular diseaseQJM: An International Journal of Medicine, 1996
- Monoclonal anticardiolipin autoantibodies established from the (new zealand white x bxsb)f1 mouse model of antiphospholipid syndrome cross‐react with oxidized low‐density lipoproteinArthritis & Rheumatism, 1995
- Early onset of autoimmunity in MRL/++ mice following immunization with β2 glycoprotein IClinical and Experimental Immunology, 1995
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in LeprosyLupus, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).Journal of Clinical Investigation, 1992
- Beyond CholesterolNew England Journal of Medicine, 1989